Reply
Tian Yang, Han Zhang, Jun Han, Meng‐Chao Wu, Feng Shen – 10 December 2016
Tian Yang, Han Zhang, Jun Han, Meng‐Chao Wu, Feng Shen – 10 December 2016
Marina Artemova, Dzhamal Abdurakhmanov, Tatiana Ignatova, Nikolay Mukhin – 10 December 2016
Kojiro Taura, Toshimi Kaido, Takayuki Anazawa, Shintaro Yagi, Hideaki Okajima, Shinji Uemoto – 9 December 2016
Margaret V. Ragni, Abhinav Humar, Peter G. Stock, Emily A. Blumberg, Bijan Eghtesad, John J. Fung, Valentina Stosor, Nicholas Nissen, Michael T. Wong, Kenneth E. Sherman, Donald M. Stablein, Burc Barin – 9 December 2016 – Hepatitis C virus (HCV) infection is the leading cause of liver disease in hemophilia patients. In those with human immunodeficiency virus (HIV)/HCV coinfection, the rate of liver disease progression is greater than in HCV monoinfected individuals. Despite antiretroviral therapy, which slows HCV liver disease progression, some require transplantation.
Suk Kyun Hong, Kwang‐Woong Lee, Hyo‐Sin Kim, Kyung Chul Yoon, Sung‐Woo Ahn, Jin Yong Choi, Hyeyoung Kim, Nam‐Joon Yi, Kyung‐Suk Suh – 9 December 2016
Javier Brahm, Fernando Contreras – 5 December 2016
Romina Fiorotto, Mario Strazzabosco – 30 November 2016
Marcelo Kugelmas, Mitchell Shiffman – 30 November 2016
Marco Carbone, Pietro Invernizzi – 30 November 2016
Ahmad H. Ali, Keith D. Lindor – 30 November 2016